HejuruUbuyobozi bukurikira
Umurongo wa HHS Section 1557 ku byerekeye algorithms z'ubuvuzi
Sosiyete
UMUYOBOZI W'umuryango
ONC’s HTI-1 final rule updates the Health IT Certification Program and establishes transparency requirements for predictive decision support interventions in certified health IT.
Umva iki gitaboAI-byavuzwe · ~3 min
The requirements apply within the certification framework, not to every AI tool. Health IT developers disclose defined source attributes so clinical users can assess appropriateness, validity, safety, effectiveness, and fairness.
The Health Data, Technology, and Interoperability (HTI-1) final rule updates ONC’s Health IT Certification Program. One part addresses algorithm transparency for predictive decision support interventions in certified health IT. ONC describes these requirements as providing clinical users with a consistent baseline of information to assess algorithms for fairness, appropriateness, validity, effectiveness, and safety. The rule focuses on certified health IT and defined predictive decision support interventions. It does not create a blanket disclosure requirement for every AI product used in healthcare. Developers must identify whether a function falls within the relevant certification criteria and provide required source attributes. Health systems should understand the certified product scope and use available documentation when evaluating a tool. Transparency supports evaluation, but disclosure alone does not show that a model performs well or is safe. Users still need to consider local population, workflow, data quality, clinical evidence, and ongoing monitoring. The rule became effective in March 2024, and organizations should check current ONC materials for implementation details and corrections. Do not confuse HTI-1 transparency requirements with FDA device authorization or other privacy and safety obligations. Implementation requires understanding whether a decision-support function is offered through certified health IT and which version is in use. A deployment may include multiple algorithms, so one disclosure should not be assumed to describe every feature. Clinicians need information in a form that supports practical review during their workflow.
A certified EHR developer documents source attributes for a predictive decision-support function.
A clinic checks whether an algorithm is within the certified health IT scope before applying HTI-1 requirements.
A clinician reviews available information about a model’s intended use and limitations.
An implementation team maps each predictive intervention to the required transparency criteria.
Algorithm transparency may make it easier for clinicians to inspect baseline information about decision-support tools. It cannot replace independent evaluation, governance, or regulatory review. ONC may issue implementation updates, and certified developers may revise products. Health systems should maintain a process to review disclosures, ask vendors questions, and reassess interventions after changes. Transparent information is most useful when users can access it before relying on a recommendation and have a route to raise concerns. Support user questions promptly and clearly.
Ibaruwa y'amakuru y'ubuntu
Inkuru eshatu zizewe za AI buri gitondo cy'iminsi y'akazi, zanditse mu rurimi rworoshye. Ubuntu iteka ryose, nta kwamamaza.
Imeri imwe buri munsi y'akazi. Kwiyimura mu buryo bumwe. Ntitwigera tugurisha cyangwa ngo dusangire aderesi yawe.
Isuzume
Ibisubizo ako kanya kuri buri kibazo, n'icyemezo gishobora gusangirwa gifite ID yagenzurwa umaze gutsinda isomo.
Fasha uburezi bwa AI bw'ubuntu. AI Understanding ni umuryango utegamiye kuri leta wa 501(c)(3) — nta kwamamaza, nta kwishyura, iteka ryose. Tanga impano
ONC’s HTI-1 final rule updates the Health IT Certification Program and establishes transparency requirements for predictive decision support interventions in certified health IT. The requirements apply within the certification framework, not to every AI tool. Health IT developers disclose defined source attributes so clinical users can assess appropriateness, validity, safety, effectiveness, and fairness.
ONC describes these evaluation dimensions for clinical users.
Disclosure is not a substitute for evidence and local evaluation.
HTI-1 certification and FDA device rules are distinct frameworks.
Komeza wige
Abandi bayobozi batoranijwe kuriyi ngingo
HejuruUbuyobozi bukurikira
Umurongo wa HHS Section 1557 ku byerekeye algorithms z'ubuvuzi
Sosiyete